These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 11584760)

  • 1. [Caspofungin. A new antimycotic agents from the echinocandin group].
    Hennemann A
    Med Monatsschr Pharm; 2001 Sep; 24(9):282-4. PubMed ID: 11584760
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of caspofungin and the echinocandins in the antifungal armamentarium.
    Morrison VA
    Curr Opin Investig Drugs; 2002 Oct; 3(10):1432-6. PubMed ID: 12431014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caspofungin.
    Chandrasekar PH; Manavathu EK
    Drugs Today (Barc); 2002 Dec; 38(12):829-46. PubMed ID: 12582472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [First echinocandin on the market. New type of antifungal against Aspergillus & Co].
    MMW Fortschr Med; 2002 Apr; 144 Suppl 1():83-4. PubMed ID: 12043093
    [No Abstract]   [Full Text] [Related]  

  • 5. Caspofungin: the first of a new class of antifungal agents.
    Valgus JM
    Cancer Pract; 2001; 9(6):314-6. PubMed ID: 11879335
    [No Abstract]   [Full Text] [Related]  

  • 6. Caspofungin (Cancidas) for aspergillosis.
    Med Lett Drugs Ther; 2001 Jul; 43(1108):58-9. PubMed ID: 11445777
    [No Abstract]   [Full Text] [Related]  

  • 7. A randomized double-blind study of caspofungin versus amphotericin for the treatment of candidal esophagitis.
    Villanueva A; Arathoon EG; Gotuzzo E; Berman RS; DiNubile MJ; Sable CA
    Clin Infect Dis; 2001 Nov; 33(9):1529-35. PubMed ID: 11588698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New type of antifungal approved for invasive aspergillosis.
    Thompson CA
    Am J Health Syst Pharm; 2001 Apr; 58(7):558, 560. PubMed ID: 11296601
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined antifungal treatment of visceral mucormycosis with caspofungin and liposomal amphotericin B.
    Voitl P; Scheibenpflug C; Weber T; Janata O; Rokitansky AM
    Eur J Clin Microbiol Infect Dis; 2002 Aug; 21(8):632-4. PubMed ID: 12226700
    [No Abstract]   [Full Text] [Related]  

  • 10. Caspofungin versus amphotericin B for invasive candidiasis.
    Brown AL; Greig JR
    N Engl J Med; 2003 Mar; 348(13):1287-8; author reply 1287-8. PubMed ID: 12660396
    [No Abstract]   [Full Text] [Related]  

  • 11. Caspofungin in combination with itraconazole for the treatment of invasive aspergillosis in humans.
    Rubin MA; Carroll KC; Cahill BC
    Clin Infect Dis; 2002 Apr; 34(8):1160-1. PubMed ID: 11915012
    [No Abstract]   [Full Text] [Related]  

  • 12. Caspofungin.
    Deresinski SC; Stevens DA
    Clin Infect Dis; 2003 Jun; 36(11):1445-57. PubMed ID: 12766841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caspofungin versus amphotericin B for the treatment of Candidal esophagitis.
    Chocarro Martínez A; Gonzalez A; Garcia I
    Clin Infect Dis; 2002 Jul; 35(1):107; author reply 107-8. PubMed ID: 12060888
    [No Abstract]   [Full Text] [Related]  

  • 14. Resolution of fungemia due to Fusarium species in a patient with acute leukemia treated with caspofungin.
    Apostolidis J; Bouzani M; Platsouka E; Belasiotou H; Stamouli M; Harhalakis N; Boutati EI; Paniara O; Nikiforakis E
    Clin Infect Dis; 2003 May; 36(10):1349-50. PubMed ID: 12746788
    [No Abstract]   [Full Text] [Related]  

  • 15. Progressive cutaneous hyalohyphomycosis due to Paecilomyces lilacinus: rapid response to treatment with caspofungin and itraconazole.
    Safdar A
    Clin Infect Dis; 2002 May; 34(10):1415-7. PubMed ID: 11981740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hitting a new target with echinocandins. Why chase something else?
    Graybill JR
    Curr Opin Investig Drugs; 2001 Apr; 2(4):468-71. PubMed ID: 11566000
    [No Abstract]   [Full Text] [Related]  

  • 17. Federal Drug Administration panel recommends approval of Cancidas, Merck's investigational antifungal drug.
    J Assoc Nurses AIDS Care; 2001; 12(4):93-4. PubMed ID: 11486726
    [No Abstract]   [Full Text] [Related]  

  • 18. Caspofungin. L 743872, MK 0991, MK 991.
    Drugs R D; 1999 Feb; 1(2):165-7. PubMed ID: 10566014
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful treatment with caspofungin of hepatosplenic candidiasis resistant to liposomal amphotericin B.
    Sorà F; Chiusolo P; Piccirillo N; Pagano L; Laurenti L; Farina G; Sica S; Leone G
    Clin Infect Dis; 2002 Nov; 35(9):1135-6. PubMed ID: 12384850
    [No Abstract]   [Full Text] [Related]  

  • 20. New antifungal drugs and the pediatric cancer patient: current status of clinical development.
    Groll AH; Lehrnbecher T
    Klin Padiatr; 2005; 217(3):158-68. PubMed ID: 15858708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.